Previous 10 | Next 10 |
Caladrius Biosciences, Inc. (CLBS) Q1 2021 Results Earnings Conference Call May 06, 2021, 04:30 PM ET Company Participants John Menditto - Vice President, Investor Relations and Corporate Communications David Mazzo - President and Chief Executive Officer James Nisco - Vice President, Finance ...
Caladrius Biosciences (CLBS): Q1 GAAP EPS of -$0.19 misses by $0.10.Cash, cash equivalents and marketable securities of $111.5MPress Release For further details see: Caladrius Biosciences EPS misses by $0.10
BASKING RIDGE, N.J. , May 06, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, provides a...
BASKING RIDGE, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today ...
BASKING RIDGE, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today ann...
High-Volume Penny Stocks to Watch Right Now As another week in April comes to an end, what are the best penny stocks to watch right now? While this is not a simple question by any means, there are some solid examples of penny stocks that could be worth a closer look. This is due to a co...
Caladrius Biosciences (CLBS) has filed for a mixed shelf offering of up to $150M.The filing does not necessarily indicate that a sale has begun, or will occur in the future.Caladrius shares closed today down 1.6% to $1.90. For further details see: Caladrius Bios...
Today, we take our first in-depth look at Caladrius Biosciences which recently posted fourth quarter results and put out a new investor presentation. The company's pipeline has multiple 'shots on goal' and there are a lot of key developmental milestones on the horizon. A full inve...
MediciNova (MNOV) +87% on BARDA partnership for Ibudilast development.Cemtrex (CETX) +85%.Koss Corporation (KOSS) +50%.Obalon Therapeutics (OBLN) +34%.Enveric Biosciences (ENVB) +39% on agreement to acquire exclusive license for novel molecules from Diverse Biotech.MoneyGram Interna...
Biotech Penny Stocks To Watch Right Now While penny stocks are well-known for volatility, so too are certain sectors. Possibly no other sector has continued its volatile trend throughout history better than biotechnology. With things like tech stocks, of course, R&D plays a role, an...
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...